"10.1371_journal.pone.0133214","plos one","2015-08-14T00:00:00Z","Daniela Chieffo; Claudia Brogna; Angela Berardinelli; Grazia D’Angelo; Maria Mallardi; Adele D’Amico; Paolo Alfieri; Eugenio Mercuri; Marika Pane","Department of Paediatric Neurology, Catholic University, Rome, Italy; Child Neurology and Psychiatry Unit, C. Mondino Foundation, Pavia, Italy; IRCCS Eugenio Medea, Bosisio Parini, Italy; Department of Neurosciences, Unit of Neuromuscular and Neurodegenerative Disorders, Bambino Gesù Childrens Hospital, Rome, Italy; Child and Adolescence Neuropsychiatry Unit, Department of Neuroscience Bambino Gesù Childrens Hospital, Rome, Italy","Conceived and designed the experiments: DC CB EM MP. Performed the experiments: DC CB AB MM GDA PA. Analyzed the data: DC CB PA EM MP. Contributed reagents/materials/analysis tools: DC CB AB GDA MM ADA PA EM MP. Wrote the paper: DC CB AB GDA MM ADA PA EM MP. Contributed to data collection, analysing data and reviewing the paper: DC CB AB GDA MM ADA PA EM MP.","Dr. Chieffo, Dr. Brogna, Dr. Berardinelli, Dr. DAngelo, Dr. Mallardi, Dr. DAmico, Dr. Alfieri and Dr. Pane report no disclosures. Dr. Mercuri is site PI for the PTC extension study of Ataluren in DMD, for the GSK Prosensa and Sarepta studies on exon skipping. He also receives funds from the Italian Telethon and SMA Europe. He has acted as advisory board for Acceleron Pharma, Shire and PTC Therapeutics, Inc, Prosensa.",NA,NA,NA,"2015","08","Daniela Chieffo","DC",9,TRUE,4,6,5,9,TRUE,TRUE,FALSE,0,NA,FALSE
